NRCAM variant defined by microexon skipping is a targetable cell surface proteoform in high-grade gliomas.

Sehgal P, Naqvi AS, Higgins M, Liu J, Harvey K, Jarroux J, Kim T, Mankaliye B, Mishra P, Watterson G, Fine J, Davis J, Hayer KE, Castro A, Mogbo A, Drummer C 4th, Martinez D, Koptyra MP, Ang Z, Wang K, Farrel A, Quesnel-Vallieres M, Barash Y, Spangler JB, Rokita JL, Resnick AC, Tilgner HU, De Raedt T, Powell DJ Jr, Thomas-Tikhonenko A. Cell Rep. 2025 Aug 26;44(8):116099. doi: 10.1016/j.celrep.2025.116099. Epub 2025 Aug 7. PMID: 40782352